Application 213853
- Type
- ANDA
- Sponsor
- UMEDICA LABS PVT LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 10MG BASE | No | No |
| 002 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 20MG BASE | No | No |
| 003 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 40MG BASE | No | No |
| 004 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | TABLET;ORAL | EQ 80MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213853-001 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2020-08-19 | |
| A213853-002 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2020-08-19 | |
| A213853-003 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2020-08-19 | |
| A213853-004 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2020-08-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A213853-001 | AB |
| A213853-002 | AB |
| A213853-003 | AB |
| A213853-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213853-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | BX | 2020-08-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213853-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | BX | 2020-08-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213853-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | BX | 2020-08-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213853-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | BX | 2020-08-19 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A213853-001 | BX | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213853-002 | BX | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213853-003 | BX | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213853-004 | BX | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213853-001 | BX | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213853-002 | BX | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213853-003 | BX | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213853-004 | BX | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A213853-001 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213853-002 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213853-003 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213853-004 | BX | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213853-001 | BX | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213853-002 | BX | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213853-003 | BX | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213853-004 | BX | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213853-001 | BX | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213853-002 | BX | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213853-003 | BX | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213853-004 | BX | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213853-001 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213853-002 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213853-003 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213853-004 | BX | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213853-001 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213853-002 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213853-003 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213853-004 | BX | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213853-001 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213853-002 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213853-003 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213853-004 | BX | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213853-001 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213853-002 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213853-003 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213853-004 | BX | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A213853-001 | BX | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A213853-002 | BX | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A213853-003 | BX | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A213853-004 | BX | 1 | d06236e962d9… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atorvastatin calcium | ATORVASTATIN CALCIUM | REMEDYREPACK INC. | 6600f22e-d303-4fe3-8212-accd6fb06e62 | 2026-06-09 | Warnings, Adverse reactions | 213853 ANDA213853 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | REMEDYREPACK INC. | 8821431a-c387-4b75-9540-f92bd455e961 | 2026-06-05 | Warnings, Adverse reactions | 213853 ANDA213853 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | Bryant Ranch Prepack | 20f820ba-9600-4b51-bf23-8c99e815674c | 2026-05-06 | Warnings, Adverse reactions | 213853 ANDA213853 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | Bryant Ranch Prepack | 112ae40c-b612-405b-8f68-6d4bf09f9440 | 2026-04-13 | Warnings, Adverse reactions | 213853 ANDA213853 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Direct_Rx | 0e24e7cb-1949-6686-e063-6394a90a4760 | 2026-03-06 | Warnings, Adverse reactions | 213853 ANDA213853 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | Umedica Laboratories USA Inc. | 5a7594ca-30be-4350-827f-ef745a2a7e18 | 2026-01-30 | Warnings, Adverse reactions | 213853 ANDA213853 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | NIVAGEN PHARMACEUTICALS, INC. | 7c58bf4a-4a92-4db8-89bc-4de1b5831efc | 2025-12-09 | Warnings, Adverse reactions | 213853 ANDA213853 75834-256 75834-257 75834-258 75834-255 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | REMEDYREPACK INC. | 604a011e-6c64-4895-8f6e-d28f119c4c22 | 2025-10-02 | Warnings, Adverse reactions | 213853 ANDA213853 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | Bryant Ranch Prepack | 71cd9b85-4914-4b0b-97db-7aaf25983211 | 2025-01-31 | Warnings, Adverse reactions | 213853 ANDA213853 |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | DirectRX | d076309f-313a-1c71-e053-2995a90a7bb7 | 2025-01-20 | Warnings, Adverse reactions | 213853 ANDA213853 72189-291 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | NuCare Pharmaceuticals,Inc. | f7e8c8d2-b74e-6afd-e053-6394a90af83e | 2024-02-05 | Warnings, Adverse reactions | 213853 ANDA213853 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | Proficient Rx LP | acbbd2c4-60bd-4e01-ad7a-b9b3178569f0 | 2024-01-01 | Warnings, Adverse reactions | 213853 ANDA213853 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68788-8298 | Atorvastatin calcium | Atorvastatin calcium | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 72189-291 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | DirectRX | ANDA | Current |
| 75834-255 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-255 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-255 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-255 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-255 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-255 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-256 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-256 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-256 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-256 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-256 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-256 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-257 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-257 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-257 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-257 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-257 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-257 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-258 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-258 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-258 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-258 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-258 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-258 | Atorvastatin calcium | Atorvastatin calcium | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |